Results 191 to 200 of about 4,071 (233)
Some of the next articles are maybe not open access.
RETINAL Cases & Brief Reports, 2019
Purpose: To report the persistence of choroidal lesions despite fluocinolone acetonide intravitreal implants and their resolution with oral prednisone treatment. Methods: Retrospective chart review of a birdshot chorioretinopathy patient at a tertiary referral clinic.
Shuk Kei, Cheng +3 more
openaire +2 more sources
Purpose: To report the persistence of choroidal lesions despite fluocinolone acetonide intravitreal implants and their resolution with oral prednisone treatment. Methods: Retrospective chart review of a birdshot chorioretinopathy patient at a tertiary referral clinic.
Shuk Kei, Cheng +3 more
openaire +2 more sources
Journal of Glaucoma, 2020
Precis: In eyes with uveitis and a history of fluocinolone acetonide (FA) implantation, glaucoma drainage implants (GDIs) provides excellent long-term control of intraocular pressure (IOP). Purpose: The purpose of this study was to evaluate the long-term control of IOP achieved by ...
Jessica L, Cao +5 more
openaire +2 more sources
Precis: In eyes with uveitis and a history of fluocinolone acetonide (FA) implantation, glaucoma drainage implants (GDIs) provides excellent long-term control of intraocular pressure (IOP). Purpose: The purpose of this study was to evaluate the long-term control of IOP achieved by ...
Jessica L, Cao +5 more
openaire +2 more sources
Spontaneous Dislocation of Fluocinolone Acetonide Implant Pellets From Their Suture Struts
American Journal of Ophthalmology, 2015To characterize spontaneous dislocation of the fluocinolone acetonide sustained release implant (Retisert; Bausch & Lomb) drug pellet from its strut.Retrospective, observational case series.The medical records of 224 patients in whom 407 fluocinolone acetonide implants were placed by either of 2 surgeons between 1998 and 2012 were reviewed for drug ...
Sujit Itty +5 more
openaire +2 more sources
Expert Opinion on Pharmacotherapy, 2014
Diabetic macular edema (DME) can be treated with intravitreal glucocorticoids, particularly triamcinolone acetonide, dexamethasone (DEX), and fluocinolone acetonide (FA).The pathophysiology of DME includes multiple growth factors such as VEGF and also inflammatory mediators.
Ciulla, Thomas A +3 more
openaire +3 more sources
Diabetic macular edema (DME) can be treated with intravitreal glucocorticoids, particularly triamcinolone acetonide, dexamethasone (DEX), and fluocinolone acetonide (FA).The pathophysiology of DME includes multiple growth factors such as VEGF and also inflammatory mediators.
Ciulla, Thomas A +3 more
openaire +3 more sources
FLUOCINOLONE ACETONIDE IMPLANT FOR VOGT–KOYANAGI–HARADA DISEASE
Retina, 2016To investigate the efficacy and safety of fluocinolone acetonide intravitreal implant in patients with Vogt-Koyanagi-Harada disease.A post hoc, subgroup analysis on patients with Vogt-Koyanagi-Harada was performed using data sets from two multicenter randomized trials on fluocinolone acetonide implant.
Jang Won, Heo +5 more
openaire +2 more sources
Uveitis Treated With Fluocinolone Acetonide Implants
Archives of Ophthalmology, 2009F. Viola, G. Staurenghi, R. Ratiglia
openaire +2 more sources
Intravitreal Fluocinolone Acetonide (Retisert) Implantation Using a Keratome Blade
Journal of VitreoRetinal Diseases, 2020Malini Veerappan, Pasricha +2 more
openaire +2 more sources
Anterior Chamber Migration of Fluocinolone Acetonide Intravitreal Implant
JAMA Ophthalmology, 2019Pukhraj, Rishi +2 more
openaire +2 more sources
Fluocinolone Acetonide Intravitreal Implant in the Visual Axis
JAMA Ophthalmology, 2016Elad, Moisseiev, Lawrence S, Morse
openaire +2 more sources

